cells that stably express Cas9 nuclease
| Inventor | Institute |
|---|---|
| Corrado Santocanale | National University of Ireland Galway |
| SKU: | 161756 |
|---|---|
| Product description: | MCF10AEditR cells that stably express Cas9 nuclease. The cell line is used to perform a CRISPR-Cas9 genome-wide screen to identify genes that, when lost, promote the proliferation of cells treated with sub-efficacious doses of a CDC7i |
| Gender: | Female |
| CRISPR: | Yes |
| Production details: | MCF10AEditR cells that stably express Cas9 nuclease were generated by lentiviral transduction of the Edit-R Cas9 plasmid and blasticidin-mediated selection. |
| Parental cell line: | MCF10A |
| Model description: | CRISPR |
| Disease: | Fibrocystic disease |
| Products or characteristics of interest: | CRISPR drug screening |
| Cat. #: | 161756 |
|---|---|
| Cancer types: | Breast cancer |
| Research Fields: | Cancer |
| Organism: | Human |
| Tissue: | Breast |
| Gender: | Female |
| Growth properties: | Adherent |
| Primary citation: | Rainey et al. 2017. ACS Chem Biol. 12(7):1893-1902. PMID: 28560864 |
| Storage conditions: | Liquid Nitrogen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | DMEM supplemented with 5% Horse serum, 100 ng/ml cholera toxin, 10 ?g/ml insulin, 20 ng/ml epidermal growth factor (Peprotech), 500 ng/ml hydrocortisone, 50 U/ml penicillin and 50 ?g/ml Streptomycin |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 |
| Biosafety level: | 1 |
| References: |
Rainey et al. 2017. ACS Chem Biol. 12(7):1893-1902. PMID: 28560864 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.